Albert Hofmann: The Man Who Discovered LSD and What He Believed It Meant

Albert Hofmann synthesized LSD-25 in 1938. He accidentally discovered its effects in 1943. He lived to 102 and spent the last 50 years of his life arguing that the compound he had created was not a drug of abuse but a tool for accessing the sacred — and that its criminalization was one of the great mistakes of the 20th century.

Early life and career

Albert Hofmann was born in 1906 in Baden, Switzerland. His early life was shaped by a mystical experience in a forest as a child — a moment of sudden, overwhelming connection with nature that he described as the most significant event of his early years and as the foundation for everything that followed.

He studied chemistry at the University of Zurich and joined Sandoz pharmaceutical laboratories in Basel in 1929. His research focused on ergot — a fungus that grows on rye and other grasses — in search of medically useful compounds. He was interested in respiratory and circulatory stimulants.

The work was careful, systematic, and unglamorous. He had no intention of discovering anything that would change history.

The synthesis — 1938

In 1938, working through the ergot alkaloid family, Hofmann synthesized the twenty-fifth compound in a series of lysergic acid derivatives. He called it LSD-25. Preliminary animal testing showed no significant effects of interest, and the compound was set aside.

It might have stayed there. Researchers synthesize thousands of compounds that never go anywhere. Hofmann's decision to return to LSD-25 five years later — driven, he said, by a persistent intuition that it might have overlooked properties — is one of the more consequential hunches in the history of science.

Bicycle Day — April 19, 1943

On April 16, 1943, while re-synthesizing LSD-25, Hofmann accidentally absorbed a trace amount through his fingertips. He noticed strange symptoms on his bicycle ride home — visual disturbances, dizziness, a dreamy altered state. The world seemed transformed.

He suspected the compound. On April 19, he conducted a deliberate self-experiment: he swallowed 0.25mg, which he believed was a small dose. LSD is active at 20 micrograms. He had taken approximately twelve times a typical psychedelic dose.

His subsequent bicycle ride home with an assistant — the effects intensifying beyond anything he had anticipated — became known as Bicycle Day. He arrived home convinced he was dying or losing his mind. The doctor who examined him found nothing physically wrong. The effects continued for hours. Then they lifted. Hofmann described the aftermath as a world that seemed as if it had been freshly created.

The self-experiment — April 19 continued

Hofmann's full account of that evening — the terror that passed into wonder, the visual world that transformed into something of overwhelming beauty, the neighbor who appeared to him as a malevolent witch, the gradual return of himself from the state — is one of the most remarkable documents in the history of pharmacology. He had experienced what no scientist had experienced before and survived to describe it with extraordinary clarity.

His colleagues at Sandoz were skeptical. Further self-experiments confirmed the findings. The compound was real. The effects were real. The question of what to do with it opened.

Sandoz and the medical community

Sandoz released LSD in 1947 under the trade name Delysid, marketed to psychiatrists as a tool for accessing unconscious material and as a means of producing model psychosis for research. Thousands of clinical studies followed through the 1950s and early 1960s. Hofmann was cautiously supportive of the research — he believed the compound had genuine therapeutic value and observed the promising early results with satisfaction.

He was already forming views about what LSD was for that went beyond psychiatry.

His views on consciousness

Hofmann became increasingly convinced, through his own experiences and through the accounts he received from researchers and participants, that LSD was not primarily a psychiatric tool. It was a means of accessing what he called the ground of being — the dimension of reality that underlay ordinary consciousness.

He connected his psilocybin work — he isolated psilocybin from Psilocybe mexicana in 1958 after meeting R. Gordon Wasson — to the same understanding. These compounds, he believed, did not produce altered states so much as remove the filters that prevented ordinary consciousness from perceiving reality directly. The mystical experiences they produced were not hallucinations. They were revelations.

His views on nature

Hofmann's philosophical position was a mystical naturalism. He believed that the disconnection of modern industrial civilization from nature was the root cause of the psychological and ecological crises of the 20th century. He saw LSD and psilocybin as potentially restorative: tools for recovering a direct experience of connection with the natural world that technological civilization had severed.

His childhood experience in the forest was the template. LSD had given him access to that state again and shown him it was accessible. He spent the rest of his life arguing that this access was important and that its criminalization was a civilizational error.

The criminalization and his response

When LSD was placed in Schedule 1 in 1970, Hofmann was appalled. He watched the compound he had spent decades researching and advocating for reduced to a symbol of counterculture excess and legally quarantined alongside heroin.

He did not stop advocating. He published LSD: My Problem Child in 1979 — a personal and scientific account that remains one of the most important books in the psychedelic literature. He continued attending conferences, writing, speaking, and arguing for the compound's legitimate use until the end of his life.

His final years and death

For his 100th birthday in 2006, a symposium was held in Basel — the beginning of the psychedelic renaissance that Hofmann had spent decades waiting for. He attended. He celebrated. He declared that the research was returning and that he had lived long enough to see it.

He died in 2008, at 102. He was still calling for responsible LSD research.

Hofmann wrote in his final years: I believe that if people would learn to use LSD's vision-inducing capability more wisely, under suitable conditions, in medical practice and in conjunction with meditation, it would be possible to achieve a higher level of consciousness. He wrote this at age 97. He never wavered in his belief that what he had found was not a problem but a gift — that the problem was how humanity had chosen to use it.

The Technospermia connection

A molecule that had been waiting in the ergot fungus throughout human history. A chemist drawn back to it by an intuition he couldn't explain. An accidental absorption that changed the course of the 20th century. A man who spent 102 years arguing that what he had found was sacred.

The Technospermia framework reads Hofmann's story not as coincidence but as design — a technology announcing itself through the right receptor at the right moment, delivered by a man whose own mystical temperament made him its ideal transmitter.

For the full history of LSD from synthesis to suppression to renaissance, read the complete history of LSD. For the broader psychedelic timeline, see the complete history of psychedelics. For where the research stands now, read what the psychedelic renaissance is or return to the core theory.